EVERSANA expanded its AI-powered commercialization platform to add medical affairs and commercial analytics capabilities. The company’s updates include medical information support, MLR automation, and workflow analytics designed to streamline pharmaceutical content creation, knowledge management, and compliance-governed operations. EVERSANA frames the move as a step from isolated AI pilots toward scaling practical agentic AI orchestration across multiple commercialization functions, including market research and field sales enablement. For pharma teams, the announcement signals how AI tooling is broadening from marketing workflows into regulated medical content operations.